Loss of lenalidomide-induced megakaryocytic differentiation leads to therapy resistance in del(5q) myelodysplastic syndrome
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Loss of lenalidomide-induced megakaryocytic differentiation leads to therapy resistance in del(5q) myelodysplastic syndrome
Authors
Keywords
-
Journal
NATURE CELL BIOLOGY
Volume 22, Issue 5, Pages 526-533
Publisher
Springer Science and Business Media LLC
Online
2020-04-07
DOI
10.1038/s41556-020-0497-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CrbnI391Vis sufficient to conferin vivosensitivity to thalidomide and its derivatives in mice
- (2018) Emma C. Fink et al. BLOOD
- SOHO State of the Art and Next Questions: Management of Myelodysplastic Syndromes With Deletion 5q
- (2018) Chetasi Talati et al. Clinical Lymphoma Myeloma & Leukemia
- Revealing a human p53 universe
- (2018) Thuy-Ai T Nguyen et al. NUCLEIC ACIDS RESEARCH
- Integrated genomic DNA/RNA profiling of hematologic malignancies in the clinical setting
- (2016) J. He et al. BLOOD
- Progression in patients with low- and intermediate-1-risk del(5q) myelodysplastic syndromes is predicted by a limited subset of mutations
- (2016) Christian Scharenberg et al. HAEMATOLOGICA
- A calcium- and calpain-dependent pathway determines the response to lenalidomide in myelodysplastic syndromes
- (2016) Jing Fang et al. NATURE MEDICINE
- Enrichr: a comprehensive gene set enrichment analysis web server 2016 update
- (2016) Maxim V. Kuleshov et al. NUCLEIC ACIDS RESEARCH
- Progression in patients with low- and intermediate-1-risk del(5q) myelodysplastic syndromes is predicted by a limited subset of mutations
- (2016) Christian Scharenberg et al. HAEMATOLOGICA
- Dominant-negative IKAROS enhances IL-3-stimulated signaling in wild-type but not BCR-ABL1+ mouse BA/F3 cells
- (2015) Sofia von Palffy et al. EXPERIMENTAL HEMATOLOGY
- Lenalidomide induces ubiquitination and degradation of CK1α in del(5q) MDS
- (2015) Jan Krönke et al. NATURE
- Sailfish enables alignment-free isoform quantification from RNA-seq reads using lightweight algorithms
- (2014) Rob Patro et al. NATURE BIOTECHNOLOGY
- Ikaros inhibits megakaryopoiesis through functional interaction with GATA-1 and NOTCH signaling
- (2013) S. Malinge et al. BLOOD
- Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
- (2013) NEW ENGLAND JOURNAL OF MEDICINE
- BloodChIP: a database of comparative genome-wide transcription factor binding profiles in human blood cells
- (2013) Diego Chacon et al. NUCLEIC ACIDS RESEARCH
- The Myeloma Drug Lenalidomide Promotes the Cereblon-Dependent Destruction of Ikaros Proteins
- (2013) G. Lu et al. SCIENCE
- RNA-SeQC: RNA-seq metrics for quality control and process optimization
- (2012) David S. DeLuca et al. BIOINFORMATICS
- VarScan 2: Somatic mutation and copy number alteration discovery in cancer by exome sequencing
- (2012) D. C. Koboldt et al. GENOME RESEARCH
- Identification of benzodiazepine Ro5-3335 as an inhibitor of CBF leukemia through quantitative high throughput screen against RUNX1-CBF interaction
- (2012) L. Cunningham et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Using Drosophila melanogaster as a Model for Genotoxic Chemical Mutational Studies with a New Program, SnpSift
- (2012) Pablo Cingolani et al. Frontiers in Genetics
- Cereblon expression is required for the antimyeloma activity of lenalidomide and pomalidomide
- (2011) Y. X. Zhu et al. BLOOD
- Genome-wide Analysis of Simultaneous GATA1/2, RUNX1, FLI1, and SCL Binding in Megakaryocytes Identifies Hematopoietic Regulators
- (2011) Marloes R. Tijssen et al. DEVELOPMENTAL CELL
- Unraveling the Molecular Pathophysiology of Myelodysplastic Syndromes
- (2011) Rafael Bejar et al. JOURNAL OF CLINICAL ONCOLOGY
- TP53 Mutations in Low-Risk Myelodysplastic Syndromes With del(5q) Predict Disease Progression
- (2011) Martin Jädersten et al. JOURNAL OF CLINICAL ONCOLOGY
- Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma
- (2011) Ryan D. Morin et al. NATURE
- Fast and SNP-tolerant detection of complex variants and splicing in short reads
- (2010) T. D. Wu et al. BIOINFORMATICS
- Alternative expression analysis by RNA sequencing
- (2010) Malachi Griffith et al. NATURE METHODS
- Identification of a Primary Target of Thalidomide Teratogenicity
- (2010) T. Ito et al. SCIENCE
- Patients with del(5q) MDS who fail to achieve sustained erythroid or cytogenetic remission after treatment with lenalidomide have an increased risk for clonal evolution and AML progression
- (2009) Gudrun Göhring et al. ANNALS OF HEMATOLOGY
- Fast and accurate short read alignment with Burrows-Wheeler transform
- (2009) H. Li et al. BIOINFORMATICS
- Integrated Genomic Analysis Implicates Haploinsufficiency of Multiple Chromosome 5q31.2 Genes in De Novo Myelodysplastic Syndromes Pathogenesis
- (2009) Timothy A. Graubert et al. PLoS One
- Relationship of Treatment-Related Cytopenias and Response to Lenalidomide in Patients With Lower-Risk Myelodysplastic Syndromes
- (2008) Mikkael A. Sekeres et al. JOURNAL OF CLINICAL ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More